生技原料市場規模、佔有率及成長分析（按類型、產品類型、表達系統及地區分類）－2026-2033年產業預測

預計到 2024 年，全球生技原料市場規模將達到 23.9 億美元，到 2025 年將達到 26.1 億美元，到 2033 年將達到 51.9 億美元，預測期（2026-2033 年）的複合年成長率為 9%。

全球生技原料市場正經歷顯著成長，這主要得益於製藥、農業和食品生產等各個領域對永續和創新解決方案日益成長的需求。基因工程和合成生物學等領域的生物技術進步，使得性能更優、環境效益更高的生物基原料、酵素和化學品得以開發。人們日益認知到生物技術原料有助於應對資源短缺和氣候變遷等挑戰，這進一步推動了其應用。然而，監管的複雜性和公眾認知等挑戰正在影響市場，並在市場發展和未來機會方面發揮關鍵作用。

全球生物技術原料市場促進因素

全球生物技術原料市場的主要驅動力是消費者對永續植物來源產品日益成長的需求。隨著消費者越來越關注自身健康和環境影響，他們對含有天然來源和環保成分的產品的需求顯著增加。生物技術能夠透過高效且永續的工藝生產這些成分，最大限度地減少對傳統農業技術的依賴。這一趨勢反映了消費者對潔淨標示和透明度的偏好，進一步推動了生物技術原料在食品、化妝品和製藥等各個領域的應用。總而言之，對永續性和健康的重視將繼續顯著影響市場動態。

全球生技原料市場面臨的限制因素

由於監管障礙和公眾對基因改造生物（GMO）的質疑，全球生物技術原料市場面臨嚴峻挑戰。儘管生物技術取得了長足進步，但人們對基因改造生物的安全性、環境影響和倫理問題仍然擔憂，導致消費者和監管機構都感到不安。這種疑慮氛圍可能導致對生物技術產品推出更嚴格的監管法規和標籤要求，阻礙市場擴張。為了有效克服這些障礙，產業相關人員必須優先考慮透明溝通，進行全面的安全評估，並投資於旨在建立消費者信任和消除對生物技術原料誤解的教育活動。

全球生物技術原料市場趨勢

全球生技原料市場正經歷著變革性的趨勢，這主要得益於消費者對永續和天然替代品的偏好日益成長，這些需求涵蓋食品、化妝品和製藥等多個領域。基因工程和生物製程的創新正在催生出獨特的、高性能的原料，從而提升產品性能。同時，完善的法規結構為生物技術的發展創造了有利環境，生物技術公司與傳統製造商之間的策略聯盟也促進了生物技術原料融入主流產品。這反映出市場正朝著生物基解決方案的方向轉變，這些解決方案符合具有環保意識的消費者的價值觀，並引領市場走向更永續的未來。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 專利分析

全球生物技術原料市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 創新生物技術藥物
• 生物相似藥

全球生技原料市場規模（依產品及複合年成長率分類）（2026-2033 年）

• 單株抗體
• 疫苗
• 荷爾蒙和生長因子
• 細胞激素
• 融合蛋白
• 治療酵素
• 血液因子

全球生物技術原料市場規模（按表達系統和複合年成長率分類）（2026-2033 年）

• 哺乳動物表達系統
• 微生物表現系統
• 酵母表現系統
• 植物表達系統
• 昆蟲表達系統

全球生技原料市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Novo Nordisk（Denmark）
• BASF（Germany）
• Lonza Group（Switzerland）
• DSM（Netherlands）
• Evonik Industries（Germany）
• WuXi AppTec（China）
• Samsung Biologics（South Korea）
• Biocon（India）
• Dr. Reddy's Laboratories（India）
• Divi's Laboratories（India）
• Laurus Labs（India）
• Concord Biotech（India）
• Amgen（USA）
• Genentech（USA）
• Regeneron Pharmaceuticals（USA）
• Gilead Sciences（USA）
• Celgene（USA）
• Bristol Myers Squibb（USA）
• Sanofi（France）
• GlaxoSmithKline（UK）

結論與建議

Global Biotech Ingredients Market size was valued at USD 2.39 Billion in 2024 and is poised to grow from USD 2.61 Billion in 2025 to USD 5.19 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026-2033).

The global market for biotech ingredients is experiencing significant growth, driven by the rising demand for sustainable and innovative solutions across diverse sectors, including pharmaceuticals, agriculture, and food production. Advances in biotechnology, particularly in areas like genetic engineering and synthetic biology, have facilitated the creation of bio-based ingredients, enzymes, and chemicals that provide improved performance and environmental advantages. Increased awareness of how biotech ingredients can tackle issues such as resource scarcity and climate change further supports their adoption. However, the market is shaped by challenges related to regulatory complexities and public perception, which play crucial roles in influencing its development and future opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biotech Ingredients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biotech Ingredients Market Segments Analysis

Global Biotech Ingredients Market is segmented by Type, Product, Expression System and region. Based on Type, the market is segmented into Innovative Biotech Apis and Biosimilars. Based on Product, the market is segmented into Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes and Blood Factors. Based on Expression System, the market is segmented into Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems and Insect Expression Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biotech Ingredients Market

The global biotech ingredients market is primarily driven by the increasing demand for sustainable and plant-based products. As consumers grow more aware of their health and environmental impacts, there is a noticeable shift toward products containing natural and eco-friendly ingredients. Biotechnology provides the capability to produce these ingredients through efficient and sustainable processes, thereby minimizing dependency on conventional agricultural techniques. This trend reflects consumers' preferences for clean labels and transparency, further boosting the uptake of biotech ingredients in diverse sectors, including food, cosmetics, and pharmaceuticals. Overall, the emphasis on sustainability and health continues to shape market dynamics significantly.

Restraints in the Global Biotech Ingredients Market

The global biotech ingredients market faces notable challenges due to regulatory hurdles and public skepticism regarding genetically modified organisms (GMOs). Despite advancements in biotechnology, lingering concerns about the safety, environmental implications, and ethical dimensions of GMOs contribute to apprehension among consumers and regulators alike. This atmosphere of doubt fosters stricter regulations and labeling mandates for biotech products, potentially hindering market expansion. To navigate these obstacles effectively, it is essential for industry participants to prioritize transparent communication, conduct thorough safety evaluations, and invest in educational initiatives aimed at building consumer trust and dispelling myths related to biotech ingredients.

Market Trends of the Global Biotech Ingredients Market

The global biotech ingredients market is experiencing transformative trends fueled by a rising consumer preference for sustainable and natural alternatives across multiple sectors, including food, cosmetics, and pharmaceuticals. Innovations in genetic engineering and bioprocessing are leading to the creation of unique, high-performance ingredients, enhancing product offerings. Concurrently, supportive regulatory frameworks are nurturing an environment ripe for biotech advancements, with strategic partnerships between biotech companies and traditional manufacturers enhancing integration into mainstream products. This landscape reflects a broader shift towards bio-based solutions, aligning with the values of environmentally conscious consumers and driving the market toward a more sustainable future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Biotech Ingredients Market Size by Type & CAGR (2026-2033)

• Market Overview
• Innovative Biotech Apis
• Biosimilars

Global Biotech Ingredients Market Size by Product & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors

Global Biotech Ingredients Market Size by Expression System & CAGR (2026-2033)

• Market Overview
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems

Global Biotech Ingredients Market Size & CAGR (2026-2033)

• North America (Type, Product, Expression System)
  • US
  • Canada
• Europe (Type, Product, Expression System)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Expression System)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Expression System)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Expression System)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Divi's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laurus Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concord Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations